Cargando…
Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
Although cytomegalovirus (CMV) specific cell-mediated immunity (CMI) has been suggested as a predictive marker for CMV infection, proper CMI monitoring strategy in CMV-seropositive recipients and optimal method are not defined. The aim of this study was to evaluate two interferon gamma release assay...
Autores principales: | Lee, Hyeyoung, Park, Ki Hyun, Ryu, Ji Hyeong, Choi, Ae-Ran, Yu, Ji Hyun, Lim, Jihyang, Han, Kyungja, Kim, Sang Il, Yang, Chul Woo, Chung, Byung Ha, Oh, Eun-Jee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726762/ https://www.ncbi.nlm.nih.gov/pubmed/29232714 http://dx.doi.org/10.1371/journal.pone.0189488 |
Ejemplares similares
-
Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
por: Kwon, Ji-Soo, et al.
Publicado: (2017) -
Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: A PRISMA-compliant article
por: Ruan, Yashi, et al.
Publicado: (2019) -
Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact
por: Valle-Arroyo, Jorge, et al.
Publicado: (2020) -
Torque teno virus viremia and QuantiFERON(®)-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients
por: Mafi, Sarah, et al.
Publicado: (2023) -
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
por: Kadkhoda, Kamran, et al.
Publicado: (2023)